Published in J Clin Endocrinol Metab on June 01, 2010
Adverse events associated with testosterone administration. N Engl J Med (2010) 10.94
Increased risk of non-fatal myocardial infarction following testosterone therapy prescription in men. PLoS One (2014) 6.01
Testosterone therapy and cardiovascular events among men: a systematic review and meta-analysis of placebo-controlled randomized trials. BMC Med (2013) 2.65
Risks and benefits of testosterone therapy in older men. Nat Rev Endocrinol (2013) 2.47
Screening and monitoring in men prescribed testosterone therapy in the U.S., 2001-2010. Public Health Rep (2015) 2.09
Clinical review: Endogenous testosterone and mortality in men: a systematic review and meta-analysis. J Clin Endocrinol Metab (2011) 1.74
Prevalence of the metabolic syndrome and cardiovascular disease risk in chemotherapy-treated testicular germ cell tumour survivors. Br J Cancer (2013) 1.60
Diagnosis and management of testosterone deficiency syndrome in men: clinical practice guideline. CMAJ (2015) 1.48
The risk of adverse outcomes in association with use of testosterone products: a cohort study using the UK-based general practice research database. Br J Clin Pharmacol (2013) 1.46
Effects of long-term androgen replacement therapy on the physical and mental statuses of aging males with late-onset hypogonadism: a multicenter randomized controlled trial in Japan (EARTH Study). Asian J Androl (2015) 1.39
Towards a diagnostic and therapeutic consensus in male osteoporosis. Osteoporos Int (2011) 1.33
Update: Hypogonadotropic hypogonadism in type 2 diabetes and obesity. J Clin Endocrinol Metab (2011) 1.33
Risk of Myocardial Infarction in Older Men Receiving Testosterone Therapy. Ann Pharmacother (2014) 1.25
Hypogonadism in the aging male diagnosis, potential benefits, and risks of testosterone replacement therapy. Int J Endocrinol (2012) 1.18
Testosterone induces erythrocytosis via increased erythropoietin and suppressed hepcidin: evidence for a new erythropoietin/hemoglobin set point. J Gerontol A Biol Sci Med Sci (2013) 1.17
Who Gets Testosterone? Patient Characteristics Associated with Testosterone Prescribing in the Veteran Affairs System: a Cross-Sectional Study. J Gen Intern Med (2016) 1.09
Late-onset hypogonadism: current concepts and controversies of pathogenesis, diagnosis and treatment. Asian J Androl (2014) 1.05
Aging and declining testosterone: past, present, and hopes for the future. J Androl (2012) 1.01
Risks and benefits of late onset hypogonadism treatment: an expert opinion. World J Mens Health (2013) 1.01
Hormone replacement therapy and physical function in healthy older men. Time to talk hormones? Endocr Rev (2012) 1.01
Testosterone as potential effective therapy in treatment of obesity in men with testosterone deficiency: a review. Curr Diabetes Rev (2012) 1.00
Recommendations on the diagnosis, treatment and monitoring of hypogonadism in men. Aging Male (2015) 0.97
Testosterone and insulin resistance in the metabolic syndrome and T2DM in men. Nat Rev Endocrinol (2013) 0.93
Testosterone therapy increased muscle mass and lipid oxidation in aging men. Age (Dordr) (2011) 0.93
Lowered testosterone in male obesity: mechanisms, morbidity and management. Asian J Androl (2014) 0.91
Hematological changes during androgen deprivation therapy. Asian J Androl (2012) 0.91
Testosterone deficiency and cardiovascular mortality. Asian J Androl (2015) 0.90
Testosterone and the cardiovascular system: a comprehensive review of the clinical literature. J Am Heart Assoc (2013) 0.89
Testosterone and the metabolic syndrome. Ther Adv Endocrinol Metab (2010) 0.87
The impact of drug reimbursement policy on rates of testosterone replacement therapy among older men. PLoS One (2014) 0.86
Hormones and prostate carcinogenesis: Androgens and estrogens. J Carcinog (2011) 0.86
Metabolic effects of testosterone replacement therapy on hypogonadal men with type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials. Asian J Androl (2013) 0.85
A perspective on the role of estrogen in hormone-induced prostate carcinogenesis. Cancer Lett (2012) 0.85
Cardiovascular risks and elevation of serum DHT vary by route of testosterone administration: a systematic review and meta-analysis. BMC Med (2014) 0.85
Musculoskeletal and prostate effects of combined testosterone and finasteride administration in older hypogonadal men: a randomized, controlled trial. Am J Physiol Endocrinol Metab (2013) 0.84
The treatment of late-onset hypogonadism. Turk J Urol (2014) 0.84
Androgen effects on skeletal muscle: implications for the development and management of frailty. Asian J Androl (2014) 0.83
Musculoskeletal disorders in chronic obstructive pulmonary disease. Biomed Res Int (2014) 0.83
Influence of androgens on circulating adiponectin in male and female rodents. PLoS One (2012) 0.82
Controversies in testosterone replacement therapy: testosterone and cardiovascular disease. Asian J Androl (2015) 0.82
Multiple hormonal dysregulation as determinant of low physical performance and mobility in older persons. Curr Pharm Des (2014) 0.82
Testosterone alters iron metabolism and stimulates red blood cell production independently of dihydrotestosterone. Am J Physiol Endocrinol Metab (2014) 0.82
Sex steroids and cardiovascular disease. Asian J Androl (2014) 0.82
Testosterone therapy and mortality risk. Int J Impot Res (2014) 0.82
Review of health risks of low testosterone and testosterone administration. World J Clin Cases (2015) 0.81
Male hormonal contraception. Virtual Mentor (2012) 0.81
Connecting the Lines between Hypogonadism and Atherosclerosis. Int J Endocrinol (2012) 0.81
A randomised controlled trial of a cognitive behavioural intervention for men who have hot flushes following prostate cancer treatment (MANCAN): trial protocol. BMC Cancer (2012) 0.81
Lean tissue mass and energy expenditure are retained in hypogonadal men with spinal cord injury after discontinuation of testosterone replacement therapy. J Spinal Cord Med (2014) 0.80
Androgens and prostate disease. Asian J Androl (2014) 0.80
Transdermal testosterone replacement therapy in men. Drug Des Devel Ther (2014) 0.80
An update on male hypogonadism therapy. Expert Opin Pharmacother (2014) 0.80
Outcomes of androgen replacement therapy in adult male hypogonadism: recommendations from the Italian society of endocrinology. J Endocrinol Invest (2014) 0.80
Diagnosis and treatment of hypogonadism in older men: proceed with caution. Asian J Androl (2010) 0.79
Testosterone Replacement Therapy and Cardiovascular Risk: A Review. World J Mens Health (2015) 0.79
The Cardiovascular Trial of the Testosterone Trials: rationale, design, and baseline data of a clinical trial using computed tomographic imaging to assess the progression of coronary atherosclerosis. Coron Artery Dis (2016) 0.78
Androgen activity and markers of inflammation among men in NHANES III. Am J Hum Biol (2013) 0.78
Diagnosis and Treatment of Low Testosterone among Patients with End-Stage Renal Disease. Semin Dial (2014) 0.78
Adverse effects of testosterone replacement therapy: an update on the evidence and controversy. Ther Adv Drug Saf (2014) 0.78
Testosterone, aging and survival: biomarker or deficiency. Curr Opin Endocrinol Diabetes Obes (2014) 0.78
Male Hormonal Contraception: Where Are We Now? Curr Obstet Gynecol Rep (2016) 0.78
Testosterone deficiency and replacement: Myths and realities. Can Urol Assoc J (2014) 0.78
Antenatal endogenous and exogenous glucocorticoids and their impact on immune ontogeny and long-term immunity. Semin Immunopathol (2016) 0.78
Testosterone therapy and mortality in US veterans. Asian J Androl (2012) 0.77
Comparison of the Effects of Testosterone Gels, Injections, and Pellets on Serum Hormones, Erythrocytosis, Lipids, and Prostate-Specific Antigen. Sex Med (2015) 0.77
Elevated Dihydrotestosterone is Associated with Testosterone Induced Erythrocytosis. J Urol (2015) 0.77
Reproductive endocrinology: Late-onset hypogonadism: evidence for diagnostic criteria. Nat Rev Endocrinol (2010) 0.77
Four Thrombotic Events Over 5 Years, Two Pulmonary Emboli and Two Deep Venous Thrombosis, When Testosterone-HCG Therapy Was Continued Despite Concurrent Anticoagulation in a 55-Year-Old Man With Lupus Anticoagulant. J Investig Med High Impact Case Rep (2016) 0.77
Testosterone treatment of older men--why are controversies created? J Clin Endocrinol Metab (2011) 0.77
Age-period-cohort projections of ischaemic heart disease mortality by socio-economic position in a rapidly transitioning Chinese population. PLoS One (2013) 0.77
An old emperor finds new clothing: rejuvenation in our time. Asian J Androl (2010) 0.77
Research on the steroidogenesis of proliferated Leydig cells in vitro. J Artif Organs (2013) 0.77
Aging and Sex Hormones in Males. Virulence (2016) 0.76
Serum Testosterone (T) Level Variability in T Gel-Treated Older Hypogonadal Men: Treatment Monitoring Implications. J Clin Endocrinol Metab (2015) 0.76
Effects of Saikokaryukotsuboreito on Spermatogenesis and Fertility in Aging Male Mice. Chin Med J (Engl) (2016) 0.76
Guidelines for testosterone therapy for men: how to avoid a mad (t)ea party by getting personal. J Clin Endocrinol Metab (2010) 0.76
Systemic hypotensive effects of testosterone are androgen structure-specific and neuronal nitric oxide synthase-dependent. Am J Physiol Regul Integr Comp Physiol (2015) 0.76
Challenges in Testosterone Measurement, Data Interpretation, and Methodological Appraisal of Interventional Trials. J Sex Med (2016) 0.76
Strength training and testosterone treatment have opposing effects on migration inhibitor factor levels in ageing men. Mediators Inflamm (2013) 0.76
Genetically predicted testosterone and systemic inflammation in men: a separate-sample Mendelian randomization analysis in older Chinese men. PLoS One (2015) 0.76
Could androgens be relevant to partly explain why men have lower life expectancy than women? J Epidemiol Community Health (2015) 0.76
Issues Surrounding Testosterone Replacement Therapy. Hosp Pharm (2016) 0.75
Androgen Therapy and Rehospitalization in Older Men With Testosterone Deficiency. Mayo Clin Proc (2016) 0.75
Testosterone deficiency in the aging male. Ther Adv Urol (2016) 0.75
Androgen actions on endothelium functions and cardiovascular diseases. J Geriatr Cardiol (2016) 0.75
Comment on: Jones et al. Testosterone replacement in hypogonadal men with type 2 diabetes and/or metabolic syndrome (the TIMES2 Study). Diabetes Care 2011;34:828-837. Diabetes Care (2011) 0.75
Editor's Comment--How Dangerous is Testosterone Supplementation? Int Braz J Urol (2015) 0.75
Testosterone Deficiency - Establishing A Biochemical Diagnosis. EJIFCC (2015) 0.75
Clomiphene Citrate Effectively Increases Testosterone in Obese, Young, Hypogonadal Men. Reprod Syst Sex Disord (2015) 0.75
Effects of Testosterone Therapy on Cognitive Function in Aging: A Systematic Review. Cogn Behav Neurol (2016) 0.75
The cost of seeking an edge: Recurrent renal infarction in setting of recreational use of anabolic steroids. Ann Med Surg (Lond) (2017) 0.75
Study clarifies associations between hypogonadism and health in aging men. Asian J Androl (2012) 0.75
Stable Intraprostatic Dihydrotestosterone in Healthy Medically Castrate Men Treated With Exogenous Testosterone. J Clin Endocrinol Metab (2016) 0.75
The Role of the Multiple Hormonal Dysregulation in the Onset of "Anemia of Aging": Focus on Testosterone, IGF-1, and Thyroid Hormones. Int J Endocrinol (2015) 0.75
A mild decrease of renal function is related to increased hemoglobin level during 5-year follow-up period. Korean J Intern Med (2014) 0.75
An update on testosterone, HDL and cardiovascular risk in men. Clin Lipidol (2015) 0.75
Erectile dysfunction, metabolic syndrome, and cardiovascular risks: facts and controversies. Transl Androl Urol (2017) 0.75
A Mendelian randomization study of testosterone and cognition in men. Sci Rep (2016) 0.75
Effect of testosterone on hepcidin, ferroportin, ferritin and iron binding capacity in patients with hypogonadotropic hypogonadism and type 2 diabetes. Clin Endocrinol (Oxf) (2016) 0.75
Endogenous testosterone level and testosterone supplementation therapy in chronic obstructive pulmonary disease (COPD): a systematic review and meta-analysis. BMJ Open (2013) 0.75
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 56.72
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 41.47
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 26.95
Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet (2008) 13.15
Adverse events associated with testosterone administration. N Engl J Med (2010) 10.94
Early detection of prostate cancer: AUA Guideline. J Urol (2013) 9.14
Internet-based learning in the health professions: a meta-analysis. JAMA (2008) 8.74
Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies. Lancet (2006) 8.61
Randomized trials stopped early for benefit: a systematic review. JAMA (2005) 8.43
Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol (2007) 7.79
Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Thyroid (2011) 7.17
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab (2010) 7.15
Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis. Arch Intern Med (2007) 6.68
Effects of Testosterone Treatment in Older Men. N Engl J Med (2016) 6.66
Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab (2008) 6.48
Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Dir Assoc (2011) 5.96
Stopping randomized trials early for benefit and estimation of treatment effects: systematic review and meta-regression analysis. JAMA (2010) 5.90
Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline. J Clin Endocrinol Metab (2006) 5.58
We need minimally disruptive medicine. BMJ (2009) 5.35
Grading quality of evidence and strength of recommendations for diagnostic tests and strategies. BMJ (2008) 5.16
The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab (2008) 4.90
Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab (2011) 4.73
Evaluation and management of adult hypoglycemic disorders: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab (2008) 4.68
Paget's disease of bone: an endocrine society clinical practice guideline. J Clin Endocrinol Metab (2014) 4.63
Association between industry funding and statistically significant pro-industry findings in medical and surgical randomized trials. CMAJ (2004) 4.53
The diabetes mellitus medication choice decision aid: a randomized trial. Arch Intern Med (2009) 4.41
Need for expertise based randomised controlled trials. BMJ (2005) 4.34
Conducting systematic reviews of diagnostic studies: didactic guidelines. BMC Med Res Methodol (2002) 4.19
Effect of testosterone replacement on response to sildenafil citrate in men with erectile dysfunction: a parallel, randomized trial. Ann Intern Med (2012) 4.18
Endocrine treatment of transsexual persons: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab (2009) 4.04
Management of hyperglycemia in hospitalized patients in non-critical care setting: an endocrine society clinical practice guideline. J Clin Endocrinol Metab (2012) 4.02
Technology-enhanced simulation for health professions education: a systematic review and meta-analysis. JAMA (2011) 3.81
The idolatry of the surrogate. BMJ (2011) 3.81
Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab (2010) 3.80
A new 'mechanistic-practical" framework for designing and interpreting randomized trials. J Clin Epidemiol (2008) 3.75
Persistence of hepatitis C virus in patients successfully treated for chronic hepatitis C. Hepatology (2005) 3.71
Development of a theory of implementation and integration: Normalization Process Theory. Implement Sci (2009) 3.68
Cost: the missing outcome in simulation-based medical education research: a systematic review. Surgery (2012) 3.62
Instructional design variations in internet-based learning for health professions education: a systematic review and meta-analysis. Acad Med (2010) 3.56
GRADE guidelines 6. Rating the quality of evidence--imprecision. J Clin Epidemiol (2011) 3.54
Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Endocr Pract (2011) 3.40
Adverse events associated with testosterone replacement in middle-aged and older men: a meta-analysis of randomized, placebo-controlled trials. J Gerontol A Biol Sci Med Sci (2005) 3.14
Computerized virtual patients in health professions education: a systematic review and meta-analysis. Acad Med (2010) 3.12
Association between lipoprotein-associated phospholipase A2 and cardiovascular disease: a systematic review. Mayo Clin Proc (2007) 3.12
Problems with use of composite end points in cardiovascular trials: systematic review of randomised controlled trials. BMJ (2007) 3.06
Thyroid cancer: zealous imaging has increased detection and treatment of low risk tumours. BMJ (2013) 3.05
Ultrasound-based transient elastography for the detection of hepatic fibrosis: systematic review and meta-analysis. Clin Gastroenterol Hepatol (2007) 2.93
Rectal nonsteroidal anti-inflammatory drugs are superior to pancreatic duct stents in preventing pancreatitis after endoscopic retrograde cholangiopancreatography: a network meta-analysis. Clin Gastroenterol Hepatol (2013) 2.91
Helping patients with type 2 diabetes mellitus make treatment decisions: statin choice randomized trial. Arch Intern Med (2007) 2.82
Statins are associated with a reduced risk of hepatocellular cancer: a systematic review and meta-analysis. Gastroenterology (2012) 2.74
Investing in deliberation: a definition and classification of decision support interventions for people facing difficult health decisions. Med Decis Making (2010) 2.73
Comparative effectiveness for survival and renal function of partial and radical nephrectomy for localized renal tumors: a systematic review and meta-analysis. J Urol (2012) 2.73
Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab (2014) 2.72
Bisphosphonates are associated with reduced risk of colorectal cancer: a systematic review and meta-analysis. Clin Gastroenterol Hepatol (2012) 2.70
Testosterone and cardiovascular risk in men: a systematic review and meta-analysis of randomized placebo-controlled trials. Mayo Clin Proc (2007) 2.63
Understanding patients' experiences of treatment burden in chronic heart failure using normalization process theory. Ann Fam Med (2011) 2.59
An observational study found that authors of randomized controlled trials frequently use concealment of randomization and blinding, despite the failure to report these methods. J Clin Epidemiol (2004) 2.58
Bilateral internal thoracic artery harvest and deep sternal wound infection in diabetic patients. Ann Thorac Surg (2013) 2.54
Prevention and treatment of pediatric obesity: an endocrine society clinical practice guideline based on expert opinion. J Clin Endocrinol Metab (2008) 2.52
Let the patient revolution begin. BMJ (2013) 2.50
Evaluation and treatment of hypertriglyceridemia: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab (2012) 2.49
Risks and benefits of testosterone therapy in older men. Nat Rev Endocrinol (2013) 2.47
GRADE guidelines: 15. Going from evidence to recommendation-determinants of a recommendation's direction and strength. J Clin Epidemiol (2013) 2.46
Clinical review: behavioral interventions to prevent childhood obesity: a systematic review and metaanalyses of randomized trials. J Clin Endocrinol Metab (2008) 2.45
Statins for the prevention and treatment of infections: a systematic review and meta-analysis. Arch Intern Med (2009) 2.43
Phenotypic effects of leptin replacement on morbid obesity, diabetes mellitus, hypogonadism, and behavior in leptin-deficient adults. Proc Natl Acad Sci U S A (2004) 2.41
Posttransplantation diabetes: a systematic review of the literature. Diabetes Care (2002) 2.39
What do we mean by web-based learning? A systematic review of the variability of interventions. Med Educ (2010) 2.38
Author self-citation in the diabetes literature. CMAJ (2004) 2.38
Improving understanding in the research informed consent process: a systematic review of 54 interventions tested in randomized control trials. BMC Med Ethics (2013) 2.38
The impact of penicillin resistance on short-term mortality in hospitalized adults with pneumococcal pneumonia: a systematic review and meta-analysis. Clin Infect Dis (2006) 2.37
Castration-resistant prostate cancer: AUA Guideline. J Urol (2013) 2.36
Sexual abuse and lifetime diagnosis of somatic disorders: a systematic review and meta-analysis. JAMA (2009) 2.34
Sarcopenia with limited mobility: an international consensus. J Am Med Dir Assoc (2011) 2.34
Synthesizing evidence: shifting the focus from individual studies to the body of evidence. JAMA (2013) 2.31
Clinical review: treatment of pediatric obesity: a systematic review and meta-analysis of randomized trials. J Clin Endocrinol Metab (2008) 2.21
Ethical issues in stopping randomized trials early because of apparent benefit. Ann Intern Med (2007) 2.21
Systematic reviewers neglect bias that results from trials stopped early for benefit. J Clin Epidemiol (2007) 2.20
Early stopping of randomized clinical trials for overt efficacy is problematic. J Clin Epidemiol (2008) 2.18
Cumulative complexity: a functional, patient-centered model of patient complexity can improve research and practice. J Clin Epidemiol (2012) 2.16
Surgical modifications of the upper airway for obstructive sleep apnea in adults: a systematic review and meta-analysis. Sleep (2010) 2.15
The chest pain choice decision aid: a randomized trial. Circ Cardiovasc Qual Outcomes (2012) 2.15